Dennis Clark, MD
General Surgery · Anniston, ALNPI 1356313969
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $855 of the $970 with a category attached, or 88.2%. It is spread thinly across 16 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $240 and has fallen 67.4% since, to $78 in 2025.
Across 46 payments — averaging $21.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$217
- AbbVie$192
- Integra Lifesciences Corporation$164
- Bard Peripheral Vascular, Inc.$64
- TELA Bio, Inc.$62
- Davol Inc.$59
- plus $213 from 10 others
What the payments were for
- Speaking & faculty fees$11512%
- Food & beverage$85588%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 13 | $217 |
| AbbVie(2 entities) | 7 | $192 |
| Integra Lifesciences Corporation | 5 | $164 |
| Bard Peripheral Vascular, Inc. | 4 | $64 |
| TELA Bio, Inc. | 4 | $62 |
| Davol Inc. | 2 | $59 |
| Intuitive Surgical | 1 | $58 |
| Mozarc Medical US LLC | 1 | $26 |
| Medtronic(2 entities) | 2 | $25 |
| Innocoll Pharmaceuticals Limited | 1 | $19 |
| Mallinckrodt Enterprises LLC | 1 | $16 |
| Covidien LP | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| TEI Biosciences Inc | 1 | $14 |
| Cumberland Pharmaceuticals, Inc. | 1 | $13 |
| Intra-sana Laboratories | 1 | $10 |
How this compares
$970 in reported general payments places this provider in the 70th percentile of 28 general surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 147 | $3,069 |
| Ursodiol | 16 | $2,346 |
| Sucralfate | 50 | $1,245 |
| Pantoprazole Sodium | 128 | $903 |
| Ondansetron Hcl | 90 | $588 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 102 | $525 |
| Dicyclomine Hcl | 23 | $423 |
| Levothyroxine Sodium | 12 | $106 |
| Metronidazole | 13 | $76 |
Paid to pharmacies, not to this prescriber.
Other general surgery in Anniston
- George CrawfordAnniston$83K
- Richard CurtinAnniston$1K
- Stanley HewlettBirmingham$97K
- William ThompsonBirmingham$13K
- Kayellen WilloughbyBirmingham$4K
- Lee SchmittBirmingham$3K
- Terisa ThomasGadsden$1K
- Xin HuangBirmingham$909
- Andrea GillisBirmingham$552
- Lacey SwensonBirmingham$540
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.